Infectious Disease and Microbiology – Septic Arthritis

Septic arthritis is infection of a joint resulting in acute inflammation of the synovium and joint space. Although bacteria are the most important causes of acute septic arthritis, infection may also be caused by mycobacteria, fungi, and occasionally viruses.

Septic arthritis is a medical and orthopedic emergency because rapidly progressive inflammation can cause irreversible destruction of articular cartilage. Prompt arthrocentesis, antimicrobial therapy, and adequate joint drainage are central to management.

The incidence in the general population is relatively low but increases substantially in patients with preexisting joint disease or prosthetic joints.

Important risk factors include advanced age, rheumatoid arthritis or other chronic joint disease, diabetes mellitus, immunosuppression, malignancy, recent joint surgery, prosthetic joints, intra-articular injections, skin infection, trauma, animal bites, and injection drug use.

Most bacterial septic arthritis results from hematogenous spread during bacteremia. Less commonly, organisms enter through direct inoculation following trauma, surgery, injection, or an animal bite, or by contiguous spread from an adjacent infection such as osteomyelitis.

Once organisms enter the joint, bacterial proliferation and the resulting intense inflammatory response can rapidly damage cartilage. Neutrophils, cytokines, bacterial toxins, and proteolytic enzymes all contribute to articular destruction.

Staphylococcus aureus is the most important and generally the most common cause of native-joint bacterial septic arthritis in adults. Both methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) must be considered.

Streptococci are also important causes. Group B Streptococcus is particularly associated with older adults and patients with underlying illnesses.

Gram-negative bacilli should be considered particularly in older adults, immunocompromised patients, people with urinary or gastrointestinal sources of bacteremia, and patients with healthcare-associated infection.

Pseudomonas aeruginosa has an important association with injection drug use, although other organisms can also occur. The sternoclavicular and sacroiliac joints are unusual sites that should raise suspicion for infection in this population.

Neisseria gonorrhoeae remains an important cause of septic arthritis in sexually active adolescents and young adults. Disseminated gonococcal infection can produce a characteristic syndrome of migratory polyarthralgia, tenosynovitis, and pustular skin lesions, with or without subsequent purulent monoarthritis.

Animal bites can directly inoculate joints. The microbiology depends on the animal and exposure; organisms such as Pasteurella multocida should be considered following cat or dog bites.

A chronic or indolent monoarthritis raises a different microbiologic differential. Important causes include Mycobacterium tuberculosis, nontuberculous mycobacteria, and fungi such as Coccidioides and Sporothrix in appropriate epidemiologic settings.

Patients usually present with acute joint pain, swelling, warmth, and marked limitation of movement. Fever is common but may be absent, particularly in older or immunocompromised patients.

The knee is the most frequently affected native joint, followed by other large joints such as the hip, shoulder, ankle, elbow, and wrist. Most cases are monoarticular, although polyarticular septic arthritis can occur, especially in patients with bacteremia, rheumatoid arthritis, or immunosuppression.

Both active and passive range of motion are usually extremely painful because the pathological process lies within the joint. This can help distinguish septic arthritis from some periarticular disorders such as bursitis or tendinitis.

In infants and young children, presentation can be less specific. Findings include irritability, refusal to move the affected limb (pseudoparalysis), limp, or inability to bear weight. Septic arthritis of the hip is particularly important because it may be difficult to recognize clinically.

The most important diagnostic procedure is urgent arthrocentesis with examination of synovial fluid. Whenever feasible, synovial fluid and blood cultures should be obtained before antibiotics are administered, provided this does not cause a clinically important delay in treatment.

Synovial fluid should generally be sent for cell count with differential, Gram stain, and bacterial culture. Crystal analysis should also be performed when gout or calcium pyrophosphate deposition disease is possible.

Typical bacterial septic arthritis produces turbid or purulent synovial fluid with a high leukocyte count and neutrophilic predominance. A synovial WBC count greater than approximately 50,000 cells/µL increases suspicion for infection, especially with a high proportion of neutrophils.

However, a synovial WBC count below 50,000 cells/µL does not exclude septic arthritis. Lower counts can occur early in infection, in immunocompromised patients, and with certain organisms.

Conversely, very high synovial leukocyte counts are not specific for infection because severe crystal-induced arthritis can produce similar findings. Finding monosodium urate or calcium pyrophosphate crystals also does not completely exclude concomitant septic arthritis.

Synovial-fluid Gram stain has limited sensitivity, so a negative Gram stain cannot rule out infection. Synovial-fluid culture has substantially greater diagnostic importance.

At least two sets of blood cultures should generally be obtained when septic arthritis is suspected, particularly when the patient is febrile or bacteremic. Blood cultures can identify the pathogen even when synovial cultures are negative.

Inflammatory markers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) are frequently elevated. They are nonspecific and cannot independently confirm or exclude septic arthritis, but serial measurements can assist in assessing response to treatment.

Peripheral leukocytosis may occur but can also be absent. A normal peripheral WBC count therefore does not exclude joint infection.

When gonococcal infection is suspected, testing should include appropriate nucleic acid amplification tests (NAATs) from relevant genital and extragenital sites because synovial-fluid cultures may be negative.

Plain radiographs are useful as an initial study to identify underlying joint abnormalities, fractures, foreign material, or late destructive changes. Early findings may be limited to soft-tissue swelling and joint effusion.

Ultrasonography is particularly useful for identifying effusions in joints such as the hip and can guide aspiration.

MRI is highly useful when there is concern for associated osteomyelitis, deep soft-tissue infection, abscess, or difficult-to-assess joints, but imaging should not unnecessarily delay diagnostic aspiration of an accessible joint.

The major differential diagnosis includes gout, pseudogout, rheumatoid arthritis, reactive arthritis, traumatic hemarthrosis, osteoarthritis, bursitis, cellulitis, Lyme arthritis, and other inflammatory arthropathies.

Once appropriate cultures have been obtained, empiric intravenous antibiotics should be started promptly when clinical suspicion for bacterial septic arthritis is substantial.

Empiric therapy should generally provide coverage for S. aureus, including MRSA when appropriate, while additional gram-negative coverage is added according to the patient’s age, immune status, Gram-stain findings, exposure history, and local epidemiology.

A commonly used empiric approach for a seriously ill adult with a negative Gram stain is vancomycin plus a third- or fourth-generation cephalosporin, with the exact regimen adjusted to individual risk factors and local resistance patterns.

Once the organism and antimicrobial susceptibility results are known, treatment should be narrowed to targeted therapy. MSSA, for example, is generally better treated with an antistaphylococcal β-lactam such as cefazolin or nafcillin/oxacillin rather than continuing vancomycin when there is no relevant β-lactam contraindication.

The duration of treatment depends on the organism, affected joint, adequacy of drainage, presence of bacteremia or osteomyelitis, and clinical response. Many uncomplicated native-joint bacterial infections require several weeks of antimicrobial therapy, but treatment duration should be individualized rather than applying a fixed IV course to every patient.

Antibiotics alone are usually insufficient. Adequate drainage of the infected joint is a fundamental component of treatment.

Drainage may be accomplished through repeated needle aspiration, arthroscopic irrigation and drainage, or open surgical drainage. The optimal approach depends on the joint involved, amount and persistence of purulent material, organism, underlying joint anatomy, and clinical response.

Early orthopedic consultation is particularly important for hip or shoulder infection, difficult-to-drain joints, extensive infection, failure to improve, or infection involving a prosthetic joint.

Prosthetic-joint infection requires a separate management strategy combining antimicrobial treatment with decisions regarding debridement and implant retention, one-stage exchange, two-stage exchange, or removal of the prosthesis, depending on the clinical circumstances.

Septic arthritis should prompt assessment for the source of bacteremia and associated infections. In appropriate patients, clinicians should consider endocarditis, osteomyelitis, skin and soft-tissue infection, urinary infection, and other potential primary sources.

After adequate control of infection, physical therapy and progressive joint mobilization are important to preserve range of motion and function. Prolonged unnecessary immobilization can contribute to stiffness and functional impairment.

Clinical improvement is assessed through decreasing pain, swelling, fever, and inflammatory markers together with improved joint function. Persistent fever, recurrent effusion, continued bacteremia, or failure of CRP to decline should raise concern for inadequate drainage, resistant organisms, osteomyelitis, abscess, or another uncontrolled infectious focus.

Major complications include rapid cartilage destruction, joint-space narrowing, ankylosis, chronic pain, reduced range of motion, permanent joint dysfunction, osteomyelitis, sepsis, and death.

Children can additionally develop damage to the growth plate or epiphysis, potentially producing impaired limb growth or permanent deformity.

A useful clinical rule is:

Acute hot + swollen + very painful joint = septic arthritis until adequately excluded.

Do not rely on absence of fever, a normal blood WBC count, a negative Gram stain, or synovial WBC <50,000/µL to rule it out.

The core sequence is:

Urgent arthrocentesis → synovial Gram stain/culture + blood cultures → prompt empiric antibiotics → adequate joint drainage → culture-directed therapy.

Infectious Disease and Microbiology – Schistosomiasis

Schistosomiasis, also called bilharziasis, is a parasitic infection caused by blood flukes of the genus Schistosoma. Humans serve as definitive hosts, while specific freshwater snails serve as intermediate hosts.

The major species causing human disease are Schistosoma mansoni, S. haematobium, S. japonicum, S. mekongi, and S. intercalatum. The species differ geographically and in the organs predominantly affected.

S. mansoni occurs predominantly in sub-Saharan Africa, parts of the Middle East, South America, and some Caribbean regions. It primarily produces intestinal and hepatosplenic schistosomiasis.

S. haematobium is found mainly in Africa and parts of the Middle East. It predominantly involves the urinary tract and is particularly associated with hematuria, urinary obstruction, bladder-wall calcification, and an increased risk of squamous cell carcinoma of the urinary bladder.

S. japonicum occurs primarily in parts of China, the Philippines, and Indonesia, while S. mekongi occurs around the Mekong River region of Cambodia and Laos. These species primarily cause intestinal and hepatosplenic disease and can occasionally produce neurologic complications.

The major risk factor is skin contact with contaminated freshwater in an endemic region. Swimming, bathing, washing, fishing, or wading in freshwater can expose a person to infective cercariae.

Infected humans release schistosome eggs in urine or feces. When the eggs reach freshwater, they hatch and release miracidia, which infect susceptible freshwater snails.

Within the snail, the parasite develops and eventually produces free-swimming cercariae. Cercariae are released into freshwater and can directly penetrate intact human skin.

After penetrating the skin, cercariae lose their tails and become schistosomula. They enter the circulation, migrate through the lungs and liver, mature into adult male and female worms, and subsequently migrate to their characteristic venous sites.

Adult S. mansoni, S. japonicum, and S. mekongi principally inhabit the mesenteric venous system, whereas S. haematobium predominantly inhabits the vesical venous plexus surrounding the urinary bladder.

Adult worms can survive for many years. Much of the disease is not caused directly by the adult worms but by the host’s granulomatous inflammatory response to deposited eggs.

Some eggs penetrate the intestinal or bladder wall and leave the body in feces or urine. Other eggs remain trapped within tissues or embolize to organs such as the liver, lungs, brain, or spinal cord, producing chronic inflammation and fibrosis.

The earliest manifestation following skin penetration can be cercarial dermatitis, commonly called swimmer’s itch. Patients may develop an itchy, erythematous, papular or urticarial eruption at sites of cercarial penetration.

Acute schistosomiasis (Katayama syndrome) usually develops several weeks after initial infection, particularly in previously unexposed individuals. It represents a systemic hypersensitivity response associated with maturation of the worms and initiation of egg production.

Katayama syndrome may produce fever, chills, headache, malaise, myalgia, cough, abdominal pain, diarrhea, urticaria, lymphadenopathy, and hepatosplenomegaly. Marked eosinophilia is an important laboratory clue.

Chronic intestinal schistosomiasis can cause abdominal pain, diarrhea, and gastrointestinal bleeding. Persistent deposition of eggs in the intestinal wall produces granulomatous inflammation and, in some patients, polyps and fibrosis.

Chronic hepatosplenic disease occurs particularly with S. mansoni and S. japonicum. Eggs reaching the liver induce granulomas and progressive periportal fibrosis.

The classic hepatic lesion is Symmers “pipestem” fibrosis, characterized by extensive periportal fibrosis. Importantly, hepatocyte function can remain relatively preserved until advanced disease or additional hepatic pathology develops.

Progressive periportal fibrosis causes portal hypertension, which can lead to splenomegaly, ascites, collateral circulation, and esophageal or gastric varices. Variceal hemorrhage can be a life-threatening complication.

Pulmonary schistosomiasis can occur when eggs reach the pulmonary circulation, particularly in patients with severe portal hypertension. Chronic pulmonary vascular disease may eventually cause pulmonary hypertension and cor pulmonale.

Urinary schistosomiasis is classically caused by S. haematobium. The characteristic presentation is hematuria, particularly terminal hematuria, together with dysuria or other urinary symptoms.

Chronic urinary disease can cause inflammation, ulceration, fibrosis, ureteric strictures, hydronephrosis, bladder dysfunction, and eventually obstructive uropathy or renal impairment.

Long-standing S. haematobium infection is strongly associated with squamous cell carcinoma of the bladder. This is one of the most important long-term complications of urinary schistosomiasis.

Genital schistosomiasis can affect both sexes. In women, lesions may involve the vulva, vagina, cervix, uterus, or fallopian tubes. In men, the prostate, seminal vesicles, epididymis, testes, or other genital structures may be affected.

Neuroschistosomiasis results from ectopic deposition of eggs in the central nervous system. Cerebral disease may produce headache, seizures, or focal neurologic deficits, whereas spinal involvement can cause myelopathy, weakness, sensory abnormalities, and paralysis.

Diagnosis is traditionally established by demonstrating characteristic schistosome eggs in stool or urine. Because egg excretion can be intermittent or low in light infections, repeated specimens and concentration techniques can substantially increase diagnostic sensitivity.

For suspected S. haematobium infection, urine microscopy is particularly important. Egg excretion often peaks around midday, so appropriately timed urine collection can improve detection.

The morphology of the eggs helps identify the species:

S. mansoni → prominent lateral spine

S. haematobium → prominent terminal spine

S. japonicum → small lateral knob/inconspicuous spine

Serologic antibody testing can be particularly useful in travelers or patients with light infections when microscopy is negative. However, antibodies can remain detectable after cure, so serology generally cannot reliably distinguish active from previously treated infection.

Antigen-detection assays and molecular methods such as PCR can provide additional evidence of infection where available. Their availability and routine use vary by setting.

Eosinophilia is common, especially during acute infection, but its absence does not exclude schistosomiasis. Anemia may develop because of chronic blood loss or advanced disease.

Abdominal ultrasonography can demonstrate periportal fibrosis, splenomegaly, portal hypertension, and other hepatosplenic abnormalities. Urinary ultrasonography can demonstrate bladder abnormalities, hydroureter, or hydronephrosis.

Chronic S. haematobium infection may cause characteristic bladder-wall calcification on imaging. CT or MRI of the brain or spinal cord is indicated when neuroschistosomiasis is suspected.

The differential diagnosis depends on the clinical syndrome and includes other helminthic infections, malaria, visceral leishmaniasis, viral hepatitis, inflammatory bowel disease, urinary tract disorders, and other causes of eosinophilia, portal hypertension, or hematuria.

Praziquantel is the treatment of choice for essentially all major forms of schistosomiasis. Treatment is recommended for infected patients because adult worms can survive for years and continue producing eggs.

For S. mansoni and S. haematobium, the usual praziquantel regimen is a total dose of 40 mg/kg orally in one day, generally divided into two doses.

For S. japonicum and S. mekongi, a total dose of 60 mg/kg orally in one day, generally divided into three doses, is commonly used.

Praziquantel acts most effectively against mature adult worms and is less effective against immature schistosomula. Therefore, patients treated very early after exposure may require repeat treatment after the parasites have matured.

Repeat praziquantel treatment may also be considered when viable eggs continue to be detected after treatment or when infection is believed to persist. Follow-up stool or urine examinations can be used to document parasitologic response when eggs were initially detectable.

Corticosteroids may be required as adjunctive therapy in severe acute Katayama syndrome and are particularly important when significant neurologic schistosomiasis produces inflammatory CNS disease.

Advanced complications require specific management in addition to antiparasitic therapy. Portal hypertension and esophageal varices may require gastroenterologic management, while obstructive urinary disease may require urologic intervention.

Prevention depends primarily on avoiding unsafe freshwater exposure in endemic regions, improving sanitation, reducing contamination of freshwater with human urine and feces, controlling snail populations where appropriate, and population-level treatment programs in endemic communities.

The prognosis is generally good when infection is diagnosed and treated before irreversible organ damage develops. Advanced portal hypertension, pulmonary hypertension, obstructive uropathy, neurologic disease, or malignancy can substantially worsen long-term outcomes.

A useful clinical pattern to remember is:

Freshwater exposure → cercarial skin penetration → eosinophilia/Katayama fever → egg deposition → chronic organ-specific disease.

S. mansoni / S. japonicum → intestine + liver → periportal “pipestem” fibrosis → portal hypertension

S. haematobium → urinary bladder → hematuria + calcification → squamous cell carcinoma

Infectious Disease and Microbiology – Scarlet Fever

Scarlet fever is a toxin-mediated illness caused by group A Streptococcus (GAS), Streptococcus pyogenes. It is characterized by an erythematous, finely papular rash associated most commonly with streptococcal pharyngitis. The rash results from streptococcal pyrogenic (erythrogenic) exotoxins.

Scarlet fever occurs predominantly in children, particularly school-aged children, and is uncommon in adults. Its epidemiology generally parallels that of group A streptococcal pharyngitis, with infections occurring most frequently during late fall, winter, and early spring in temperate climates.

Transmission usually occurs through respiratory droplets and close contact with an infected person. Household contacts, classmates, roommates, and people living in crowded environments therefore have increased exposure.

Although pharyngitis is the classic underlying infection, toxin-producing GAS infections at other sites can occasionally produce a scarlet-fever syndrome. These include infected wounds, burns, skin infections, surgical wounds, and puerperal infections.

Scarlet fever develops when an infecting strain of GAS produces streptococcal pyrogenic exotoxins in a susceptible host. These exotoxins are responsible for the characteristic rash and other systemic manifestations.

The incubation period is usually a few days. Illness commonly begins abruptly with fever and sore throat. Associated manifestations can include chills, headache, malaise, myalgia, nausea, vomiting, and abdominal pain, particularly in children.

Examination of the throat commonly demonstrates erythematous pharyngitis or tonsillitis, sometimes with tonsillar exudates. Palatal petechiae may be present, and tender anterior cervical lymphadenopathy is common.

The characteristic rash generally appears within the first few days of illness. It usually begins on the neck, upper chest, or trunk and subsequently spreads to the remainder of the trunk and extremities.

The rash consists of numerous small erythematous papules that produce the classic fine “sandpaper” texture. It typically blanches with pressure. The palms and soles are usually spared during the initial exanthem.

The face may appear flushed, but the region immediately surrounding the mouth characteristically remains pale. This finding is known as circumoral or perioral pallor.

Another characteristic finding is Pastia’s lines. These are areas of accentuated erythema within skin folds, particularly in the antecubital fossae, axillae, and groin. They result from increased concentration of the rash and petechiae in flexural areas.

The tongue may initially have a white coating with prominent erythematous papillae, producing the appearance traditionally called a white strawberry tongue. After several days, the coating disappears and the tongue becomes intensely erythematous with prominent papillae—the classic red strawberry or raspberry tongue.

The exanthem generally resolves within approximately a week. As the rash fades, desquamation may occur. Peeling can persist for several weeks and may become particularly noticeable around the fingertips, toes, hands, and feet.

Diagnosis is based on the compatible clinical syndrome together with evidence of group A streptococcal infection. Because several illnesses can produce a scarlatiniform rash, microbiologic confirmation of GAS pharyngitis is important when appropriate.

A rapid antigen detection test can identify GAS from a throat specimen. A throat culture can also establish the diagnosis and is particularly useful when additional confirmation is required. Current testing strategies depend on the patient’s age and local clinical guidelines.

Leukocytosis may occur during acute disease, but routine blood counts are not required to establish uncomplicated scarlet fever. Antistreptococcal antibody tests such as antistreptolysin O (ASO) and anti-DNase B reflect previous streptococcal exposure and are generally more useful for evaluating delayed post-streptococcal complications than for diagnosing acute pharyngitis.

The differential diagnosis includes viral exanthems, drug eruptions, Kawasaki disease, toxic shock syndrome, staphylococcal toxin-mediated disease, measles, rubella, and other causes of a diffuse erythematous rash. Clinical context and microbiologic testing help distinguish these disorders.

Penicillin or amoxicillin is standard first-line treatment for uncomplicated GAS pharyngitis associated with scarlet fever. A conventional oral penicillin or amoxicillin course is generally given for 10 days.

Appropriate alternatives are available for patients with penicillin allergy, with the choice depending partly on whether the allergy represents immediate hypersensitivity. Options can include selected cephalosporins, clindamycin, azithromycin, or clarithromycin. Local macrolide and clindamycin resistance should be considered when selecting therapy.

Antibiotic treatment shortens the period of contagiousness, reduces transmission, improves symptoms, and—when appropriately administered for GAS pharyngitis—helps prevent acute rheumatic fever.

Patients should receive adequate fluids, rest, and symptomatic treatment for fever and throat discomfort when necessary. Severe systemic illness, hemodynamic instability, rapidly progressive soft-tissue infection, or multisystem involvement should raise concern for invasive GAS infection or streptococcal toxic shock syndrome rather than uncomplicated scarlet fever.

Patients with uncomplicated scarlet fever generally become substantially less contagious after at least 12–24 hours of appropriate antibiotic therapy and when clinically improving. Good hand hygiene, respiratory etiquette, and avoidance of sharing eating utensils can help limit household and school transmission.

The prognosis is excellent with appropriate antibiotic treatment. The fever, pharyngitis, and rash usually resolve without permanent consequences, although skin desquamation can continue after the systemic illness has resolved.

Suppurative complications of the underlying GAS infection can include peritonsillar or retropharyngeal abscess, cervical lymphadenitis, otitis media, mastoiditis, pneumonia, bacteremia, and other invasive infections.

Important delayed immune-mediated complications include acute rheumatic fever and post-streptococcal glomerulonephritis. Acute rheumatic fever typically develops several weeks after GAS pharyngitis, whereas post-streptococcal glomerulonephritis may follow either pharyngeal or certain skin infections.

A useful clinical pattern to remember is:

GAS pharyngitis + fever → sandpaper-like rash → Pastia’s lines + circumoral pallor + strawberry tongue → later desquamation = Scarlet fever.

Infectious Disease and Microbiology – Scabies

Scabies is a contagious skin infestation caused by the human itch mite, Sarcoptes scabiei var. hominis. The condition is characterized primarily by intense itching and a characteristic skin eruption caused by infestation and the host immune response to the mite.

⸻

Scabies occurs worldwide and affects people of all ages, sexes, ethnicities, and socioeconomic groups. Historically, hundreds of millions of cases have been estimated globally each year. The disease is particularly common in areas with overcrowding, limited access to healthcare, and resource-constrained living conditions.

⸻

Individuals living in institutions, crowded households, shelters, or other settings involving prolonged close contact have an increased risk of transmission. Immunocompromised individuals and frail or institutionalized older adults are particularly susceptible to severe forms of infestation.

⸻

Crusted scabies, previously called Norwegian scabies, is a severe form characterized by an extremely high mite burden. It is particularly associated with impaired cellular immunity and other conditions that reduce the ability to scratch or mount an effective immune response. Reported risk factors include immunosuppression, corticosteroid therapy, HTLV-1 infection, malnutrition, Down syndrome, and certain neurologic or cognitive conditions.

⸻

Prevention requires prompt identification and treatment of affected individuals and their close contacts. Household members and other individuals with prolonged skin-to-skin contact should generally be managed simultaneously to prevent reinfestation.

⸻

Clothing, towels, and bedding recently used by an affected person should be appropriately cleaned, usually by hot washing and hot drying. Items that cannot be washed can be isolated according to appropriate infection-control recommendations. Avoiding prolonged direct skin contact with an untreated infected person also reduces transmission.

⸻

Scabies is primarily transmitted through prolonged direct skin-to-skin contact. Transmission through contaminated clothing, bedding, or other fomites is less common in ordinary scabies but becomes considerably more important in crusted scabies because of the very large number of mites present.

⸻

After reaching the skin, fertilized female mites burrow into the superficial epidermis and deposit eggs. The eggs hatch into larvae, which subsequently develop into nymphs and adult mites.

⸻

During a person’s first infestation, symptoms commonly take several weeks to develop because manifestations depend largely on sensitization to the mites and their products. In previously infected individuals, symptoms may develop within only a few days after reinfestation.

⸻

The characteristic symptom is intense generalized pruritus, which is typically worse at night. Other household members or close contacts experiencing similar nocturnal itching can provide an important diagnostic clue.

⸻

Typical examination findings include erythematous papules, excoriations from scratching, and thin linear or serpiginous burrows. Common locations include the interdigital spaces of the fingers, flexor surfaces of the wrists, elbows, axillae, periumbilical region, waistline, buttocks, genital region, breasts, ankles, and feet.

⸻

In healthy adults, the head, face, and neck are usually spared. However, infants, young children, older adults, and immunocompromised patients may develop involvement of the scalp, face, neck, palms, or soles.

⸻

Nodular scabies presents with persistent, intensely pruritic reddish-brown or violaceous nodules, particularly around the genital region, groin, and axillae. These lesions may persist even after the mites have been successfully eradicated because of continued hypersensitivity.

⸻

Crusted scabies has a different appearance from classic scabies. Patients develop extensive hyperkeratotic, crusted, or psoriasiform plaques that may involve the hands, feet, nails, scalp, face, or other large areas of the body. Because these patients can harbor enormous numbers of mites, crusted scabies is extremely contagious.

⸻

Diagnosis is often made clinically from the combination of characteristic itching, distribution of lesions, burrows, and an appropriate exposure history. Confirmation can be obtained by demonstrating mites, eggs, or fecal material from a skin scraping examined microscopically.

⸻

Dermoscopy can assist diagnosis by allowing direct visualization of characteristic structures associated with the mite and its burrow. Videodermoscopy may provide greater magnification. Skin biopsy is rarely required but can be useful when the presentation is atypical and the diagnosis remains uncertain.

⸻

The differential diagnosis includes eczema, contact or atopic dermatitis, drug eruptions, pediculosis corporis, dermatitis herpetiformis, lichen planus, pityriasis rosea, papular urticaria, and other pruritic dermatoses.

⸻

Permethrin 5% cream is a standard first-line treatment for classic scabies. It is generally applied thoroughly over the recommended body surface, commonly from the neck downward in adults, and left in place for approximately 8–14 hours before being washed off. Treatment is commonly repeated after about one week because the initial application may not eliminate all newly developing mites.

⸻

Application must include easily overlooked areas such as between the fingers and toes, underneath the fingernails, around the umbilicus, buttocks, groin, and external genital region. In infants, older adults, and some immunocompromised patients, treatment may also need to include the scalp and other areas above the neck while avoiding the eyes and mouth.

⸻

Oral ivermectin is another important treatment option and is especially useful for outbreaks, treatment failure, difficulty applying topical therapy, or crusted scabies. A commonly used regimen is 200 micrograms/kg orally, with a second dose approximately 7–14 days later. Multiple doses combined with topical therapy are generally required for crusted scabies.

⸻

Other topical treatments include sulfur preparations and, depending on local availability, benzyl benzoate or crotamiton. Sulfur preparations have historically been useful when treatment options are limited, including in certain very young infants or during pregnancy. Treatment selection should take age, pregnancy, comorbidities, availability, and local recommendations into account.

⸻

Lindane has historically been used as an alternative scabicide but is now generally avoided or restricted because systemic absorption can cause serious neurotoxicity, including seizures. Safer alternatives are preferred whenever available.

⸻

Close contacts should generally be treated at the same time as the affected patient, even when they do not yet have symptoms, because the incubation period can be several weeks. Failure to treat contacts is an important cause of apparent treatment failure and recurrent infestation.

⸻

Recently used clothing, towels, and bedding should be cleaned at the time treatment begins. Environmental cleaning is particularly important in crusted scabies. Routine excessive cleaning or pesticide treatment of the entire home is generally unnecessary for ordinary scabies.

⸻

Antihistamines and other symptomatic treatments may help control itching. Importantly, pruritus can continue for several weeks after successful eradication because the inflammatory and hypersensitivity response does not disappear immediately.

⸻

Persistent itching shortly after treatment therefore does not necessarily indicate treatment failure. Reassessment is appropriate when symptoms continue, worsen, new burrows or characteristic lesions appear, treatment was applied incorrectly, or untreated contacts could have caused reinfestation.

⸻

Patients with crusted scabies require particularly careful management because of their high mite burden, infectiousness, and association with underlying immunosuppression or debilitating disease. Dermatology or infectious-disease consultation may be appropriate, and infection-control precautions are especially important in institutional outbreaks.

⸻

The prognosis of uncomplicated scabies is excellent with appropriate therapy. Treatment failures are most often related to incorrect application, inadequate treatment of contacts, reinfestation, or failure to recognize crusted scabies rather than true resistance.

⸻

The most important complication is secondary bacterial infection of excoriated skin, particularly with Staphylococcus aureus or Streptococcus pyogenes. Scabies can also exacerbate preexisting eczema and, in heavily affected populations, secondary streptococcal skin infection can contribute to more serious postinfectious complications.

Infectious Disease and Microbiology – Rubella (German Measles)

Rubella, also called German measles, is a contagious viral infection caused by an enveloped RNA virus belonging to the togavirus family. In most children and adults the illness is mild, but infection during pregnancy can have devastating effects on the developing fetus.

Rubella has become uncommon in countries with widespread vaccination. Historically, the incidence in the United States fell to approximately 1 case per 100,000 population, with most cases occurring among unvaccinated individuals or people arriving from areas where vaccination coverage is lower. Worldwide incidence has also declined substantially following expansion of immunization programs.

The most important risk factor for rubella is lack of vaccination. Before widespread immunization, the disease occurred predominantly in children between 5 and 14 years of age. In areas where vaccination coverage remains inadequate, infection may also occur frequently among adolescents and young adults.

Prevention depends primarily on vaccination with the live attenuated rubella vaccine, usually administered as part of the measles-mumps-rubella vaccine. Routine childhood immunization includes two doses, traditionally given around 12–15 months of age and again between 4 and 6 years.

Women of childbearing age should have their rubella immune status assessed when appropriate, particularly before pregnancy or during early prenatal care. A nonimmune woman should be vaccinated after delivery rather than during pregnancy because the vaccine contains live attenuated virus. Pregnancy should be avoided for approximately 28 days following vaccination.

If rubella vaccine is inadvertently administered during pregnancy, counseling is appropriate, but vaccination alone is not considered an automatic indication for pregnancy termination. Immunocompromised individuals receiving significant chemotherapy or undergoing bone marrow transplantation generally should not receive live rubella vaccine.

Patients with confirmed rubella should avoid close contact with susceptible individuals and should generally remain isolated for approximately one week after the rash appears. Immunoglobulin has not been considered a reliable method of preventing fetal infection in a susceptible pregnant woman after exposure.

Rubella has an incubation period of approximately 2–3 weeks. Transmission occurs primarily through respiratory droplets and secretions from the upper respiratory tract.

The infection is generally mild in children and adults but is especially important during pregnancy. Maternal infection during the first trimester and early second trimester carries the greatest risk of congenital rubella syndrome. Maternal infection may be mild or even asymptomatic while still causing significant fetal injury.

Infants with congenital rubella may continue shedding virus for many months and, in some cases, for as long as 1–2 years after birth. They can therefore remain infectious for prolonged periods.

Rubella commonly begins with a mild upper respiratory illness characterized by low-grade fever, malaise, and coryza. Some patients may have few or no symptoms before the rash develops.

Physical examination may reveal small red lesions on the soft palate followed by a fine maculopapular or morbilliform rash. The rash usually begins on the face, often around the postauricular region, and spreads downward across the trunk and extremities over the next 1–2 days. The lesions may merge and can occasionally be pruritic.

Tender postauricular and occipital lymphadenopathy is a characteristic early finding. Conjunctivitis may also occur. Adolescents and adults, particularly women, may develop arthralgia or arthritis after the rash, which can persist for several days or occasionally longer.

Congenital rubella syndrome can affect multiple organ systems. Manifestations include fetal death, growth restriction, developmental delay, sensorineural deafness, cataracts, retinopathy, patent ductus arteriosus, pulmonary artery abnormalities, hepatosplenomegaly, diabetes mellitus, and thyroid disorders. Some abnormalities may not become apparent until later childhood.

Laboratory testing may show leukopenia and atypical lymphocytes, although these findings are nonspecific. Serologic testing is commonly used to confirm infection.

Rubella-specific IgM antibodies generally become detectable within several days of illness and may remain present for several weeks. However, false-positive IgM results may occur because of infections such as measles, cytomegalovirus, Epstein-Barr virus, or parvovirus B19, as well as interference from rheumatoid factor.

Rubella IgG testing can demonstrate prior immunity, while IgG avidity testing may help distinguish recent primary infection from past infection or reinfection. When a diagnosis has major implications, particularly during pregnancy, positive serologic findings should be confirmed with additional testing when available.

Polymerase chain reaction testing can detect rubella viral RNA in respiratory secretions, blood, amniotic fluid, or fetal specimens. PCR of oral or nasopharyngeal samples is most useful during the early period after rash onset. Viral culture is available only in specialized laboratories.

The differential diagnosis includes measles, parvovirus B19 infection, enterovirus infection, HIV-associated rash, scarlet fever, and medication-related eruptions.

There is no specific antiviral treatment for uncomplicated rubella or congenital rubella syndrome. Management of acquired rubella is supportive, with rest, adequate hydration, and symptomatic treatment when necessary.

Children with congenital rubella syndrome require long-term multidisciplinary follow-up because hearing impairment, visual abnormalities, developmental problems, endocrine disorders, and cardiovascular defects may require ongoing treatment.

The prognosis of uncomplicated rubella in children and adults is excellent, with most patients recovering completely. Congenital rubella syndrome, however, may cause lifelong disability and significant multisystem disease.

The most important complication is congenital rubella syndrome following maternal infection during pregnancy. Sensorineural hearing loss is among the most frequent permanent manifestations. Other uncommon complications of acquired rubella include thrombocytopenia and acute disseminated encephalomyelitis.

Infectious Disease and Microbiology – Roundworms, Intestinal

Intestinal roundworms are clinically important nematodes that infect humans either after ingestion of eggs from contaminated food, water, or soil, or after infective larvae penetrate the skin. Important intestinal roundworm infections include trichuriasis, enterobiasis, ascariasis, hookworm infection, and strongyloidiasis.

Trichuriasis is caused by Trichuris trichiura, or whipworm, and occurs worldwide, particularly in communities with poor sanitation. Hundreds of millions of people are infected globally. Humans are the principal host, and infection is acquired by ingesting mature eggs from contaminated soil.

After ingestion, whipworm eggs hatch in the intestine, and the larvae migrate to the cecum. Adult worms reside mainly in the cecum and ascending colon and may survive for approximately one year. Diagnosis is made by stool microscopy showing characteristic thick-shelled ova with polar plugs.

Trichuriasis is commonly treated with albendazole 400 mg orally daily for 3 days in mild to moderate infection, with longer courses considered for heavier infection. Mebendazole is another effective option. Heavy worm burdens can cause chronic gastrointestinal symptoms and painful rectal prolapse.

Enterobiasis is caused by Enterobius vermicularis, commonly called pinworm. It occurs worldwide and is especially common among children, households, schools, and other crowded settings. Infection can spread rapidly among family members regardless of socioeconomic status.

Adult pinworms live in the terminal ileum and cecum. At night, female worms migrate to the perianal region to deposit eggs, producing intense itching. Scratching contaminates the hands and fingernails, allowing autoinfection and person-to-person transmission through contaminated clothing, bedding, and surfaces.

Diagnosis of enterobiasis is usually made using the cellophane or Scotch-tape test, which collects the characteristic elongated oval eggs from the perianal region. Stool microscopy is generally less useful because the eggs are deposited outside the intestinal lumen.

Treatment includes a single oral dose of albendazole 400 mg or mebendazole 100 mg, with the dose repeated after 2 weeks to reduce the risk of reinfection. Pyrantel pamoate is an alternative. Household members should generally be treated at the same time, and bedding and clothing should be thoroughly washed.

Complications of enterobiasis include perianal excoriations, secondary bacterial infection, and rarely migration of worms into the female genital tract or abdominal cavity.

Ascariasis is caused by Ascaris lumbricoides and is one of the most common human helminthic infections worldwide. It is especially prevalent in areas with poor sanitation and is commonly seen in children.

Ascaris is the largest human intestinal nematode, with adult worms reaching approximately 35 cm in length. Eggs are passed in feces and become infectious after maturing in soil. They can remain viable in the environment for years.

After infective eggs are swallowed, larvae hatch in the intestine, penetrate the intestinal wall, enter the bloodstream, and migrate to the lungs. They cross into the alveoli, ascend the respiratory tract, are swallowed, and then mature into adult worms in the small intestine. Adult worms may survive for 1–2 years.

Diagnosis is usually established by stool microscopy demonstrating characteristic thick-shelled eggs. Peripheral eosinophilia may develop during the pulmonary migration phase.

Ascariasis is usually treated with albendazole 400 mg orally as a single dose or mebendazole 100 mg twice daily for 3 days. Heavy infection can cause intestinal obstruction, impaired nutrition, and malnutrition, particularly in children.

Hookworm infection is caused predominantly by Necator americanus and Ancylostoma duodenale. It is common in tropical and subtropical regions and affects a substantial proportion of the world’s population.

Infective hookworm larvae in contaminated soil penetrate exposed skin, commonly through bare feet. The larvae enter the bloodstream, migrate to the lungs, penetrate the alveoli, ascend the respiratory tract, and are swallowed. They then attach to the mucosa of the small intestine and feed on blood.

Adult hookworms are approximately 1 cm long and may survive for many years. Chronic intestinal blood loss can result in significant iron deficiency, especially in individuals with poor nutritional reserves.

Diagnosis is made by stool microscopy showing characteristic thin-shelled, colorless eggs. Eosinophilia may occur during larval migration, while chronic disease may produce iron-deficiency anemia.

Treatment generally consists of albendazole 400 mg orally as a single dose or mebendazole for 3 days. Pyrantel pamoate is an alternative. Iron replacement may also be required in patients with significant anemia.

Severe hookworm infection may cause profound iron-deficiency anemia, malabsorption, poor growth, and failure to thrive.

Strongyloidiasis is caused by Strongyloides stercoralis and occurs mainly in tropical and subtropical regions. It is more common in rural communities, institutional settings, and populations with lower socioeconomic conditions.

Infective filariform larvae penetrate the skin following contact with contaminated soil. They enter the circulation, migrate through the lungs, penetrate the alveoli, ascend the respiratory tract, and are swallowed. Adult female worms then live in the upper small intestine.

A distinctive feature of Strongyloides infection is autoinfection. Rhabditiform larvae produced in the intestine can transform into infective filariform larvae before leaving the body. These larvae penetrate the intestinal wall or perianal skin and restart the migration cycle, allowing infection to persist for decades.

Diagnosis is based on demonstration of rhabditiform larvae in stool. Because parasite excretion may be intermittent, repeated stool examinations may be required. Eosinophilia is common in uncomplicated acute and chronic infection. Serologic testing can be useful when stool examinations are negative but clinical suspicion remains high.

Ivermectin is the preferred treatment for strongyloidiasis, usually given at 200 micrograms/kg orally daily for 2 days. A repeat course may be required. Albendazole is an alternative, although generally less effective. Hyperinfection or disseminated strongyloidiasis requires prolonged ivermectin treatment until parasitologic clearance is achieved.

Strongyloides hyperinfection is particularly dangerous in immunocompromised patients, especially those receiving corticosteroids. Large numbers of migrating larvae can cause severe gastrointestinal and pulmonary disease, intestinal microperforation, bacteremia, sepsis, and death.

General prevention of intestinal roundworm infections depends on proper sanitation, safe disposal of human waste, thorough handwashing after defecation and before food preparation, and careful washing, peeling, or cooking of fruits and vegetables. Wearing protective footwear is particularly important for preventing hookworm infection and strongyloidiasis when contact with contaminated soil is possible.

The differential diagnosis includes other intestinal helminthic infections and should be guided by exposure history, clinical manifestations, stool findings, eosinophilia, and geographic risk factors.

Follow-up stool examinations may be useful after treatment to confirm eradication and detect reinfection, particularly in persistent or high-risk infections. Enterobiasis requires attention to household transmission, while strongyloidiasis requires especially careful follow-up in immunocompromised patients.

The overall prognosis is excellent when intestinal roundworm infections are recognized and appropriately treated. However, untreated heavy infection can produce important complications, including rectal prolapse from trichuriasis, intestinal obstruction from ascariasis, severe anemia from hookworm infection, and potentially fatal hyperinfection syndrome from strongyloidiasis.

Infectious Disease and Microbiology – Rocky Mountain Spotted Fever

Rocky Mountain spotted fever (RMSF) is an acute tick-borne infection caused by the intracellular bacterium Rickettsia rickettsii. Despite its name, most cases in the United States occur outside the Rocky Mountain region. The disease can progress rapidly and may be fatal if treatment is delayed.

RMSF is a reportable disease in the United States, with hundreds to a few thousand cases historically reported each year. Although cases have occurred across most states, a large proportion have been concentrated in North Carolina, Oklahoma, Arkansas, Tennessee, and Missouri. RMSF also occurs in Canada, Mexico, Central America, and South America.

The disease is most common during spring and summer, when tick activity is highest. Children younger than 10 years and adults between 40 and 64 years have historically had high incidence rates. Risk increases with residence or activity in wooded areas, tall grass, and places where dogs and ticks are common. Glucose-6-phosphate dehydrogenase deficiency has been associated with more severe disease in some patients.

Prevention depends on reducing tick exposure. People entering wooded or grassy environments should wear protective clothing, perform frequent tick checks, and consider repellents containing DEET on exposed skin and permethrin on clothing where appropriate. Attached ticks should be removed promptly using fine-tipped forceps, grasping the tick close to the skin and pulling steadily upward without twisting.

After a tick bite, R. rickettsii enters vascular endothelial cells and spreads through the vascular system. Infection produces widespread vasculitis, increasing vascular permeability and activating coagulation pathways. The resulting capillary leak, edema, hypovolemia, and tissue ischemia account for many of the systemic manifestations and complications of RMSF.

Rickettsia rickettsii is an obligate intracellular, gram-negative coccobacillus transmitted through the salivary glands of feeding ticks. Important vectors include Dermacentor variabilis, the American dog tick, in much of the eastern United States, and Dermacentor andersoni, the Rocky Mountain wood tick, in western regions. The brown dog tick, Rhipicephalus sanguineus, can transmit infection in parts of Arizona and Mexico, while Amblyomma species have been important vectors in Central and South America.

The incubation period is generally 2–14 days, averaging about 7 days. Illness usually begins abruptly with fever, severe headache, myalgias, and marked malaise. Nausea, vomiting, and abdominal pain are also common. Neurologic involvement may range from mild confusion to seizures and encephalitis. Importantly, many patients do not recall a tick bite.

The classic triad of fever, rash, and known tick exposure is uncommon early in the disease and should not be required for diagnosis. The rash typically appears 2–5 days after fever begins. It usually starts as small blanching erythematous macules on the wrists and ankles, then spreads to the palms, soles, arms, legs, and trunk. As disease progresses, the lesions may become petechial.

The rash may appear late or may never develop. A minority of patients have so-called spotless RMSF. In addition, the rash may be difficult to recognize in people with darker skin tones. Therefore, absence of rash does not exclude the diagnosis.

Ocular abnormalities may include conjunctivitis, retinal vascular changes, hemorrhages, arterial occlusion, and papilledema. Neurologic findings may include lethargy, photophobia, meningismus, transient hearing loss, amnesia, behavioral changes, seizures, or encephalopathy. Hepatomegaly and pulmonary findings resembling pneumonia can also occur.

Diagnosis requires a high degree of clinical suspicion because laboratory confirmation is often unavailable during the early phase when treatment is most important. Antibodies against R. rickettsii are generally not detectable until approximately 7–10 days after illness begins.

Indirect immunofluorescence antibody testing is the traditional reference serologic method. Diagnosis is supported by a fourfold rise in antibody titer between acute and convalescent specimens. A single positive result may be difficult to interpret because antibodies to other spotted-fever rickettsiae may cross-react and background seropositivity can occur.

Thrombocytopenia is one of the most common laboratory abnormalities. The white blood cell count may be normal, decreased, or elevated and is not sufficiently reliable to exclude the disease. Other abnormalities may include hyponatremia, elevated creatinine, azotemia, increased serum transaminases, bilirubin elevation, and increased creatine kinase.

Chest radiographs may demonstrate focal pulmonary infiltrates or interstitial edema. In patients with encephalopathy, CT or MRI may reveal generalized cerebral edema. Cerebrospinal fluid may show a mild lymphocytic pleocytosis. Electrocardiographic abnormalities may range from nonspecific ST-wave changes to atrial arrhythmias.

Direct immunofluorescence staining of a skin biopsy for R. rickettsii antigens can provide early diagnostic evidence, although it is not routinely available and is generally less practical than clinical diagnosis and serology.

The differential diagnosis is broad and includes viral syndromes, bacterial sepsis, meningococcemia, disseminated gonococcal infection, secondary syphilis, typhoid fever, leptospirosis, ehrlichiosis, anaplasmosis, toxic shock syndrome, drug hypersensitivity reactions, idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura, and bacterial or viral meningoencephalitis.

Treatment should begin immediately when RMSF is suspected and must not be delayed while awaiting laboratory confirmation. Doxycycline is the treatment of choice for both adults and children. Adults are generally treated with doxycycline 100 mg twice daily, while children weighing less than 45 kg receive approximately 2.2 mg/kg per dose twice daily.

Therapy is typically continued for at least 5–7 days and for at least 48 hours after the patient becomes afebrile and shows clear clinical improvement. Oral or intravenous therapy may be used depending on severity and the patient’s ability to tolerate oral medications.

Doxycycline is also recommended for young children despite historical concerns about tooth staining because short courses have not shown the same risk associated with prolonged tetracycline exposure, and delayed effective therapy can be life-threatening.

Chloramphenicol has historically been used as an alternative, particularly when tetracyclines were considered contraindicated. However, outcomes have generally been less favorable than with doxycycline, and treatment decisions in pregnancy or other special circumstances require individualized risk-benefit assessment.

Severely ill patients may require hospitalization and intensive supportive care. Intravenous antibiotics are appropriate for patients with persistent vomiting, unstable vital signs, altered mental status, or other signs of severe disease. Shock, renal failure, respiratory compromise, and neurologic deterioration may require intensive care, hemodynamic support, mechanical ventilation, or renal replacement therapy.

Patients with neurologic symptoms, elevated creatinine, significant vomiting, hypotension, or other unstable vital signs should generally be admitted to the hospital. Approximately one-fourth of suspected cases historically required hospitalization.

The prognosis is strongly influenced by how quickly effective treatment is started. Delay beyond the first several days of illness substantially increases the risk of death and severe complications. Older age, neurologic involvement, renal dysfunction, and failure to receive doxycycline are associated with poorer outcomes.

Most survivors recover fully, but severe disease may produce permanent neurologic deficits, hearing impairment, or tissue ischemia severe enough to cause gangrene and require amputation.

Major complications include meningitis, encephalitis, seizures, acute kidney injury, acute respiratory distress syndrome, shock, disseminated vascular injury, myocarditis, tissue necrosis, and multiorgan failure.

Infectious Disease and Microbiology – Rheumatic Fever

Rheumatic fever is an inflammatory clinical syndrome that develops following infection of the pharynx with group A Streptococcus. It can produce a wide range of manifestations, including migratory arthritis, characteristic skin lesions, Sydenham chorea, and pancarditis with cardiac valvular dysfunction.

⸻

Rheumatic fever occurs worldwide but has become relatively uncommon in developed countries because of improved living conditions and appropriate antibiotic treatment of streptococcal pharyngitis. It remains an important cause of acquired heart disease in developing countries, historically accounting for approximately 40% of heart disease in some populations. The estimated incidence in the United States has been approximately 0.5 per 100,000 population, with a prevalence of about 2 per 10,000. It primarily affects children between 6 and 15 years of age.

⸻

Approximately one-third of cases may follow subacute or clinically unrecognized group A streptococcal pharyngitis. Historically, the attack rate after untreated streptococcal pharyngitis has ranged from approximately 0.4–3%. Outbreaks may be influenced by the particular circulating strains of Streptococcus.

⸻

Important risk factors include overcrowded living conditions and a previous history of rheumatic fever. Genetic susceptibility has also been proposed, with associations involving certain HLA types, B-cell alloantigens, and immune-response gene polymorphisms, although the precise genetic contribution remains incompletely understood.

⸻

Prevention begins with appropriate diagnosis and treatment of group A streptococcal pharyngitis. A complete course of penicillin therapy can prevent the development of rheumatic fever even when treatment is initiated several days after the onset of sore throat. Patients with a previous episode of rheumatic fever have a substantial risk of recurrence and therefore require secondary antibiotic prophylaxis. Benzathine penicillin G administered intramuscularly at regular intervals is a commonly used regimen, with oral penicillin or certain alternative antibiotics used when appropriate.

⸻

The pathogenesis of rheumatic fever is primarily immune mediated. Molecular mimicry between antigens of group A Streptococcus and human tissues produces an abnormal immune response in which antibodies and immune cells directed against streptococcal components cross-react with host tissues, particularly structures within the heart.

⸻

Group A streptococcal pharyngitis initiates the disease. Rheumatic fever typically develops approximately 1–5 weeks after the infection, with an average interval historically reported at about 19 days. Certain streptococcal strains have been particularly associated with rheumatic fever. Cross-reacting immune responses against streptococcal antigens and cardiac tissues, especially heart valves, contribute to the development of carditis.

⸻

Patients may present with fever, fatigue, joint pain, skin manifestations, involuntary movements, dyspnea, or peripheral edema. Rheumatic fever is fundamentally a clinical diagnosis. Traditionally, diagnosis is based on the Jones criteria together with evidence of a preceding group A streptococcal infection. The clinical manifestations may persist for several months, particularly when carditis is present.

⸻

The major clinical manifestations include migratory polyarthritis, carditis, Sydenham chorea, subcutaneous nodules, and erythema marginatum. Historically, polyarthritis has occurred in approximately 75% of cases, carditis in about 50%, chorea in approximately 15%, and subcutaneous nodules and erythema marginatum in fewer than 10%.

⸻

Polyarthritis commonly occurs early in the disease and is frequently accompanied by fever. The arthritis predominantly involves large joints, particularly the knees, ankles, elbows, and wrists. Several joints may become involved sequentially, producing the characteristic migratory pattern. Joint manifestations generally resolve without permanent damage.

⸻

Carditis may involve the endocardium, myocardium, and pericardium, producing pancarditis. Some cases are clinically subtle, whereas severe disease may present with congestive heart failure. Acute valvular involvement most commonly produces mitral regurgitation, followed by aortic regurgitation. Persistent valvular damage can eventually result in chronic rheumatic heart disease.

⸻

Sydenham chorea consists of irregular, involuntary, purposeless, dance-like movements involving the face and extremities. It may occur together with arthritis and carditis or occasionally appear as the predominant manifestation of rheumatic fever.

⸻

Subcutaneous nodules are painless lesions that usually develop over tendons or near joints. They may reach approximately 2 cm in diameter and are particularly associated with rheumatic carditis.

⸻

Erythema marginatum is an uncommon, transient rash consisting of irregular erythematous lesions, usually involving the trunk and extremities. Because the lesions are evanescent, the rash may be difficult to detect during examination.

⸻

Minor manifestations include fever and arthralgia without objective arthritis. Laboratory or electrocardiographic abnormalities contributing to the traditional minor criteria include elevated inflammatory markers such as erythrocyte sedimentation rate or C-reactive protein and prolongation of the PR interval on electrocardiography.

⸻

Evidence of a preceding group A streptococcal infection should generally be established. This may include a positive throat culture, positive rapid streptococcal antigen testing, or elevated or rising streptococcal antibody titers such as antistreptolysin O, anti-DNase B, or antihyaluronidase antibodies. Exceptions may occur with manifestations such as Sydenham chorea or indolent carditis, which can appear sufficiently late that evidence of the original infection is difficult to demonstrate.

⸻

Echocardiography is an important component of evaluation because it can detect valvular abnormalities and carditis that may not be obvious on physical examination. Serial echocardiography may be required when cardiac involvement progresses or when monitoring established carditis.

⸻

Pathologically, rheumatic fever produces inflammatory lesions within connective tissues. Characteristic Aschoff bodies may be found in the myocardium. Cardiac inflammation can involve all layers of the heart, resulting in pancarditis.

⸻

The differential diagnosis includes juvenile idiopathic arthritis, systemic lupus erythematosus, Lyme disease, gonococcal arthritis, infective endocarditis, viral infections such as rubella and coxsackievirus infection, medication reactions, sickle cell disease, sarcoidosis, inflammatory bowel disease, leukemia, and other causes of inflammatory arthritis or cardiac disease.

⸻

Treatment is directed toward eradication of group A streptococcal infection, suppression of inflammation, management of cardiac complications, and prevention of recurrent disease. Anti-inflammatory therapy with aspirin or other appropriate anti-inflammatory agents has historically been used for arthritis and other inflammatory manifestations. Corticosteroids may be considered in severe carditis, particularly when significant heart failure is present.

⸻

Older treatment regimens used high-dose aspirin, sometimes beginning at approximately 90–100 mg/kg/day and subsequently reducing the dose after clinical improvement. Corticosteroid therapy has historically been used for severe inflammatory cardiac disease. Because aspirin and corticosteroid regimens require careful consideration of toxicity and current clinical recommendations, treatment should be individualized and supervised appropriately.

⸻

Secondary antibiotic prophylaxis is a central component of long-term management because recurrent streptococcal infections can cause additional episodes of rheumatic fever and progressively worsen valvular disease. The required duration depends on whether the initial episode involved carditis and whether residual valvular disease remains.

⸻

Patients with rheumatic fever accompanied by carditis and persistent valvular disease generally require prolonged prophylaxis, historically for at least 10 years or until approximately 40 years of age, whichever is longer. Some individuals at continued high risk of streptococcal exposure or recurrent disease may require lifelong prophylaxis.

⸻

When carditis occurred but no residual cardiac disease remains, prophylaxis has traditionally been continued for approximately 10 years or until at least 21 years of age, whichever period is longer. In rheumatic fever without carditis, prophylaxis is generally continued for at least 5 years or until approximately 21 years of age, whichever is longer. Sydenham chorea as a manifestation of rheumatic fever also warrants secondary prophylaxis.

⸻

Severe valvular disease that fails medical management may require cardiothoracic surgical evaluation. Rheumatic heart disease remains an important indication for valve surgery in regions where rheumatic fever is common. Procedures may include mitral valve repair, commissurotomy, or valve replacement, depending on the type and severity of valvular damage.

⸻

Hospitalization may be necessary for patients with significant carditis, heart failure, severe Sydenham chorea, or other serious manifestations. Discharge is generally appropriate when symptoms are adequately controlled and there is no evidence of uncontrolled heart failure.

⸻

Patients with carditis require long-term clinical and echocardiographic follow-up, often involving both primary care and cardiology specialists. Education regarding adherence to secondary antibiotic prophylaxis is particularly important because recurrent attacks substantially increase the risk of permanent valvular damage.

⸻

The overall prognosis depends largely on the severity of cardiac involvement and the occurrence of recurrent episodes. Many patients recover from the acute illness, but recurrence can occur following subsequent group A streptococcal infections, particularly when secondary prophylaxis is inadequate.

⸻

The most important long-term complication is chronic rheumatic valvular heart disease. Progressive valve dysfunction can eventually result in refractory heart failure, arrhythmias, pulmonary hypertension, and the need for cardiac surgery. Patients with damaged valves may also have an increased risk of infective endocarditis.

Infectious Disease and Microbiology – Respiratory Syncytial Virus Infection

Respiratory syncytial virus (RSV) is a highly contagious viral infection that causes upper and lower respiratory tract disease in children and adults. It is particularly important in infants, children with congenital heart or chronic lung disease, immunocompromised individuals, and older adults. Acute bronchiolitis is the major clinical manifestation in young children.

RSV is one of the most important causes of lower respiratory tract infection in childhood. In 2005, an estimated 33.8 million episodes of RSV-associated acute lower respiratory tract infection occurred worldwide among children younger than 5 years, with an estimated 66,000–199,000 associated deaths. Severe RSV disease occurs most frequently between 2 and 8 months of age. By 24 months, most children have experienced at least one RSV infection. RSV also causes substantial disease in older adults, with annual attack rates historically estimated at approximately 5–10%.

Important risk factors for severe RSV infection include age younger than 6 months, prematurity, male sex, crowding, lower socioeconomic conditions, exposure to passive cigarette smoke, day-care attendance, older siblings attending day care, and birth during the early part of RSV season. Children with congenital heart disease, chronic lung disease such as bronchopulmonary dysplasia or cystic fibrosis, and individuals who are immunocompromised because of chemotherapy or transplantation are also at increased risk.

Prevention focuses on reducing viral transmission and protecting individuals at high risk of severe disease. Frequent handwashing, avoiding the sharing of contaminated objects, and appropriate infection-control precautions can reduce transmission. Glove and gown precautions are particularly important in healthcare environments. Historically, passive immunization with RSV-specific immunoglobulin and the monoclonal antibody palivizumab has been used for selected high-risk infants. Motavizumab was investigated as a more potent monoclonal antibody against RSV.

RSV spreads from the upper respiratory tract into the lower respiratory tract. Viral infection promotes cell-to-cell fusion, producing characteristic multinucleated structures known as syncytia. Infection and inflammation of the small airways contribute to airway obstruction, mucus production, wheezing, and the characteristic manifestations of bronchiolitis.

Severe RSV bronchiolitis during infancy has been associated with an increased prevalence of recurrent wheezing and asthma later in childhood. Some studies have suggested that RSV prophylaxis may reduce recurrent wheezing in certain nonatopic children, although the relationship between RSV infection, atopy, and subsequent asthma is complex.

The incubation period of RSV is approximately 2–8 days. Transmission occurs through contact with infected respiratory secretions, contaminated hands or surfaces, and respiratory droplets. Infection commonly begins with upper respiratory symptoms and may progress rapidly to cough, coryza, and wheezing. Fever is usually low-grade, although high fever can occur in children.

As the disease progresses, young children may develop a deeper cough, episodes of coughing, wheezing, and manifestations of bronchiolitis. Mild croup may occur, and otitis media is a frequent associated condition. Older adults may develop more significant lower respiratory tract disease, including bronchopneumonia.

Physical examination of infants with RSV lower respiratory tract infection may demonstrate tachypnea, diffuse rales associated with small-airway disease, wheezing, and, in severe cases, cyanosis. Otitis media may also be present. Careful assessment of hydration is particularly important in infants and should include evaluation of skin turgor, capillary refill, and the condition of the mucous membranes.

Laboratory assessment in patients with significant illness may include measurement of oxygen saturation, arterial blood gases, serum electrolytes, and a complete blood count. RSV can be identified from respiratory secretions using rapid diagnostic tests. Other diagnostic techniques include immunofluorescence assays, enzyme-linked immunosorbent assays, and viral culture of nasal washings.

Chest radiographs may demonstrate hyperinflation, focal atelectasis, and pulmonary infiltrates. Expiratory CT imaging may show evidence of small-airway disease, particularly air trapping. Histopathologic examination of lung tissue can demonstrate mononuclear cell and neutrophil infiltration around bronchioles, together with areas of atelectasis and pulmonary infiltrates.

The differential diagnosis includes asthma, acute or chronic bronchitis, bacterial or viral pneumonia, influenza, parainfluenza infection, croup, human metapneumovirus infection, and neonatal sepsis.

Treatment is primarily supportive. Oxygen should be administered when clinically indicated, and adequate hydration should be maintained with oral or intravenous fluids depending on the patient’s condition. Respiratory support, including mechanical ventilation or intubation, may be necessary in severe disease.

Nebulized ribavirin has historically been approved for severe RSV infection. A regimen described is 6 g of lyophilized ribavirin dissolved in 300 mL of distilled water and administered through a small-particle aerosol generator for 12–20 hours per day for 3–7 days. However, evidence supporting substantial clinical benefit has been limited, and concerns include cost and potential occupational exposure of healthcare workers. Its use has therefore generally been reserved for selected severe cases, particularly among profoundly immunocompromised patients.

Various additional approaches have been investigated in high-risk populations. Intravenous palivizumab, alone or in combination with ribavirin, has been studied in severe RSV infection. Combination regimens involving inhaled ribavirin, corticosteroids, intravenous immunoglobulin, and sometimes palivizumab have also been evaluated in transplant recipients. RNA interference therapies have additionally been investigated in lung transplant patients.

Hospitalized patients require careful supportive management. Oxygenation and hydration should be monitored closely, and patients with progressive respiratory failure may require assisted ventilation. Young infants, immunocompromised patients, individuals with significant cardiopulmonary disease, and older adults are at increased risk of severe outcomes.

Most otherwise healthy children hospitalized with RSV infection improve sufficiently for discharge within several days. Follow-up is generally unnecessary after uncomplicated recovery, although patients who subsequently develop persistent or recurrent bronchospasm may require additional evaluation.

The prognosis is generally favorable in healthy children, but RSV can cause substantial morbidity and mortality in young infants, older adults, and individuals with underlying cardiopulmonary disease or immunocompromising conditions. A small but important proportion of infants with RSV infection require intermediate or intensive care.

Potential complications include bacterial pneumonia, otitis media, respiratory failure, and recurrent wheezing. Neurologic complications such as seizures and encephalopathy have also been reported. Severe childhood RSV infection has been associated with subsequent asthma or recurrent wheezing, although the precise causal relationship remains uncertain.

Ophthalmology – Hypertensive Retinopathy

Basics

Description

Hypertensive retinopathy refers to characteristic retinal, choroidal, and optic nerve changes produced by systemic hypertension. The ocular findings may be divided broadly into acute changes, usually associated with severe or rapidly rising blood pressure, and chronic changes, which reflect longstanding vascular damage.

Acute severe hypertension may cause retinal ischemia, hemorrhages, cotton-wool spots, hard exudates, choroidal infarction, serous retinal detachment, and optic disc edema. Chronic hypertension produces progressive retinal arteriolar narrowing, vascular wall thickening, arteriovenous crossing abnormalities, and eventually copper- or silver-wiring of the retinal arteries.

Pregnancy Considerations

In a woman of childbearing age with severe or uncontrolled hypertension, pregnancy status should be established because hypertension may be related to preeclampsia or eclampsia. These conditions can produce marked retinal and choroidal changes and may threaten both maternal and fetal health.

Epidemiology

The frequency of hypertensive retinopathy varies between populations and depends on the definition used.

In the Beaver Dam Eye Study, approximately 6% of patients developed hypertensive retinopathy. Retinal arteriolar narrowing was noted in about 9.9%, while arteriovenous nicking occurred in approximately 6.5%.

Reported prevalence among adults older than 40 years ranges from roughly 2–15%. Some studies have found a higher prevalence among African American populations than among Caucasian populations.

Risk Factors

The principal risk factor is elevated systemic blood pressure, including both systolic and diastolic hypertension.

Diabetes mellitus increases the risk and severity of retinal vascular damage.

Other cardiovascular risk factors, particularly dyslipidemia, smoking, obesity, renal disease, and atherosclerosis, may contribute to the overall vascular burden.

Genetics

There is no single genetic cause of hypertensive retinopathy. Multiple genetic factors contribute to the development of systemic hypertension and therefore indirectly influence susceptibility to hypertensive retinal vascular changes.

General Prevention

Prevention centers on maintaining well-controlled systemic blood pressure.

Regular blood pressure monitoring, adherence to prescribed antihypertensive therapy, control of diabetes and dyslipidemia, appropriate diet, exercise, and management of other cardiovascular risk factors reduce the likelihood of hypertensive end-organ damage.

Pathophysiology

As systemic blood pressure rises, the retinal arterioles initially respond with vasoconstriction. Persistent hypertension eventually causes structural thickening of the arteriolar walls.

With more severe hypertension, the blood-retinal barrier becomes disrupted, allowing leakage of plasma, lipid, and blood into the retina.

Damage to small retinal vessels causes ischemia, producing cotton-wool spots and other manifestations of retinal infarction.

Severe acute hypertension may also compromise the choroidal circulation and optic nerve blood supply, producing choroidal infarcts, retinal pigment epithelial abnormalities, optic nerve ischemia, and optic disc edema.

Etiology

The most common cause is essential hypertension.

Secondary causes include renal disease, renal artery stenosis, endocrine disorders, pregnancy-related hypertension such as preeclampsia/eclampsia, and other systemic conditions capable of producing severe elevations in blood pressure.

Commonly Associated Conditions

Hypertensive retinopathy is associated with systemic and ocular vascular disease, including diabetes mellitus, hyperlipidemia, atherosclerosis, retinal artery macroaneurysm, retinal vein occlusion, retinal artery occlusion, stroke, and cognitive decline.

Longstanding systemic hypertension may also be associated with an increased cardiovascular risk, including coronary artery disease.

Diagnosis

History

Many patients with hypertensive retinopathy are asymptomatic and may not even know that they have hypertension.

Others have a known history of elevated blood pressure and may be receiving antihypertensive medication.

Patients should be asked about headaches, visual changes, neurologic symptoms, chest pain, shortness of breath, renal disease, pregnancy, diabetes, and medication adherence.

In acute severe hypertension, symptoms related to end-organ injury may dominate the presentation.

Physical Examination

A complete ophthalmic examination should include visual acuity, pupils, intraocular pressure when appropriate, slit-lamp examination, and a dilated fundus examination.

The retinal appearance differs substantially between acute severe hypertension and chronic hypertension.

Acute or Malignant Hypertensive Changes

Severe or rapidly developing hypertension can cause fibrinoid necrosis of the retinal and choroidal arterioles, producing ischemic and exudative changes.

Deep yellow-gray retinal pigment epithelial or choroidal lesions may be seen during the acute phase.

Later, areas of choroidal infarction can become hyperpigmented and are called Elschnig spots.

Linear hyperpigmented streaks resulting from choroidal infarction along choroidal arteries are known as Siegrist streaks.

Optic Disc Edema

Optic disc swelling may occur in very severe hypertensive disease.

It reflects significant end-organ involvement and may result from ischemic injury to the optic nerve and disruption of autoregulation.

Historically, optic disc edema was an important feature in definitions of malignant hypertension.

The presence of optic disc edema in a patient with severely elevated blood pressure should be considered a medical emergency requiring urgent systemic evaluation.

Retinal Hemorrhages

Hypertensive retinopathy may produce retinal hemorrhages of varying severity.

These may include:

Flame-shaped hemorrhages in the nerve fiber layer, deeper dot-blot hemorrhages, and occasionally more extensive pre-retinal or subretinal hemorrhage in severe disease.

Cotton-Wool Spots

Cotton-wool spots represent localized infarctions of the retinal nerve fiber layer caused by precapillary arteriolar occlusion.

They indicate significant retinal ischemia and are more likely in severe hypertension.

Hard Exudates

Breakdown of the blood-retinal barrier permits lipid-rich plasma to leak into the retina, producing hard exudates.

When arranged radially around the fovea, they may create a macular star.

Serous Retinal Detachment

Acute severe hypertension, particularly in younger patients or those with pregnancy-associated hypertension, can produce serous retinal detachment because of choroidal ischemia and retinal pigment epithelial dysfunction.

This may cause sudden visual loss.

Chronic Hypertensive Changes

Longstanding hypertension produces structural changes in the retinal arterioles.

Arteriolar Narrowing

Generalized or focal narrowing of the retinal arterioles is common.

The normal artery-to-vein caliber ratio is approximately 2:3. With chronic hypertension, the arterial component becomes progressively narrower.

Copper Wiring

As the arteriolar wall becomes thickened and sclerotic, the central light reflex broadens.

The vessel develops a reddish-brown appearance referred to as copper wiring.

Silver Wiring

With advanced arteriolosclerosis, the arterial wall becomes so thick and opaque that the blood column is difficult or impossible to visualize.

The vessel then appears pale or white, producing silver wiring.

Arteriovenous Nicking

At arteriovenous crossings, the artery and vein share a common adventitial sheath.

A thickened, rigid artery can compress the underlying vein, producing narrowing or interruption of the venous blood column.

This is termed AV nicking, or the Gunn sign.

Salus Sign

The retinal vein may be deflected from its normal course as it passes beneath a sclerotic arteriole.

This is known as the Salus sign.

Microaneurysms

Microaneurysms may develop as a consequence of chronic microvascular damage.

However, their presence should also prompt consideration of diabetes or other retinal vascular disease.

Diagnostic Tests and Interpretation

Blood Pressure Measurement

The most important initial systemic test is accurate blood pressure measurement.

If severe hypertension is found, assessment for acute end-organ damage should follow promptly.

Patients with diabetes should have careful blood pressure control because reduction of systemic hypertension decreases progression of diabetic microvascular complications.

Imaging

Routine ocular imaging is not always necessary in straightforward cases.

However, several modalities may be useful when the diagnosis is uncertain or complications are suspected.

Fundus Photography

Color fundus photography is useful for documenting the severity and progression of retinal vascular changes.

Optical Coherence Tomography

OCT may reveal macular edema, subretinal fluid, retinal thickening, or structural changes associated with severe hypertensive retinopathy.

Fluorescein Angiography

Fluorescein angiography may demonstrate:

Microaneurysms, retinal telangiectasia, retinal or choroidal ischemia, capillary nonperfusion, vascular leakage, and optic disc leakage.

It is generally reserved for cases in which additional information is needed.

Pathological Findings and Grading

A traditional grading system is the Scheie classification.

Grade 0: Normal fundus.

Grade 1: Mild generalized retinal arteriolar narrowing.

Grade 2: More obvious narrowing with focal irregularities.

Grade 3: Grade 2 changes plus retinal hemorrhages, cotton-wool spots, or exudates.

Grade 4: Grade 3 changes plus optic disc edema.

Modern clinical management places more emphasis on the presence of acute end-organ injury than on the grading system alone.

Differential Diagnosis

Important differential diagnoses include diabetic retinopathy, radiation retinopathy, retinal vein occlusion, retinal artery occlusion, retinal vasculitis, juxtafoveal telangiectasia, giant cell arteritis, and other ischemic or inflammatory retinal vascular disorders.

The patient’s systemic history and retinal distribution of lesions help distinguish these conditions.

Treatment

Treatment is directed primarily at the systemic hypertension, not the retinal lesions themselves.

The retinal changes frequently improve as blood pressure is controlled.

Medication

Chronic Hypertension

Patients with chronic hypertension generally require oral antihypertensive therapy chosen according to their overall cardiovascular and renal status.

Medication selection should be managed by the patient’s primary care physician, internist, cardiologist, nephrologist, or other appropriate clinician.

Hypertensive Emergency

Patients with severe hypertension and evidence of acute end-organ damage may require intravenous antihypertensive therapy in a monitored hospital setting.

Blood pressure should generally be lowered in a controlled manner rather than abruptly, because excessive rapid reduction can compromise cerebral, coronary, renal, and ocular perfusion.

Referral

All patients with newly recognized hypertensive retinopathy should have systemic blood pressure evaluation and appropriate medical follow-up.

Patients with severe retinal hemorrhages, cotton-wool spots, optic disc edema, choroidopathy, neurologic symptoms, or other evidence of acute hypertensive end-organ damage require urgent medical assessment.

Inpatient Considerations

Hospital admission is indicated when the patient has a hypertensive emergency, meaning severely elevated blood pressure accompanied by acute target-organ injury.

Ocular evidence of severe hypertensive damage, particularly optic disc edema together with other systemic findings, may form part of the end-organ injury picture.

Management requires controlled blood pressure lowering and evaluation for neurologic, cardiac, renal, and other systemic complications.

Follow-Up

Blood pressure should be monitored closely by the patient’s medical provider.

Ophthalmic follow-up depends on the severity of retinal findings.

Patients with mild chronic changes may be followed during routine dilated eye examinations.

Patients with acute exudative or ischemic changes should be re-examined more closely to document resolution of hemorrhages, cotton-wool spots, retinal edema, subretinal fluid, and optic disc swelling.

Diet

A diet that supports blood pressure control is recommended.

For patients with salt-sensitive hypertension, reduction of dietary sodium can contribute to improved blood pressure control.

Overall cardiovascular dietary measures should also emphasize appropriate calorie intake, fruits, vegetables, whole grains, and management of dyslipidemia and diabetes.

Patient Education

Patients should understand that hypertensive retinopathy is evidence of systemic vascular injury, not merely an isolated eye problem.

Regular blood pressure monitoring, adherence to antihypertensive medication, treatment of diabetes and hyperlipidemia, smoking cessation, and regular medical follow-up are important for preserving both vision and overall cardiovascular health.

Patients with sudden visual loss, severe headache, neurologic symptoms, chest pain, or severe blood pressure elevation should seek urgent medical care.

Prognosis

The visual prognosis is usually excellent when blood pressure is adequately controlled before permanent retinal, choroidal, or optic nerve damage develops.

Many acute retinal changes, including hemorrhages, cotton-wool spots, and edema, can improve substantially after appropriate treatment of systemic hypertension.

Longstanding vascular sclerosis may remain even after blood pressure is controlled.

Severe ischemic injury to the macula or optic nerve may result in permanent visual impairment.

Complications

Complications of systemic hypertension affecting the eye include retinal vein occlusion, retinal arterial occlusion, retinal artery macroaneurysm, optic nerve ischemia, hypertensive optic neuropathy, macular edema, choroidal infarction, and serous retinal detachment.

The presence of significant hypertensive retinopathy also serves as an important marker of increased risk for systemic cardiovascular and cerebrovascular disease.